How has Integra LifeSciences's other commercial liabilities changed year-over-year?

Integra LifeSciences's other commercial liabilities decreased by 3.0% year-over-year, from $137.42M to $133.32M.

What is the long-term trend for Integra LifeSciences's other commercial liabilities?

Over 5 years (2020 to 2025), Integra LifeSciences's other commercial liabilities has grown at a 6.7% compound annual growth rate (CAGR), from $94.19M to $130.49M.

Integra LifeSciences IART Other Commercial Liabilities

Other Commercial Liabilities at other companies

Becton, Dickinson and CompanyBDX

——

Globus MedicalGMED

——

STERISSTE

——

ITG

Integer HoldingsITGR

——

Merit Medical SystemsMMSI

——

Boston ScientificBSX

——

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's other commercial liabilities?: Integra LifeSciences (IART) reported other commercial liabilities of $133.32M in Q1 2026.
How has Integra LifeSciences's other commercial liabilities changed year-over-year?: Integra LifeSciences's other commercial liabilities decreased by 3.0% year-over-year, from $137.42M to $133.32M.
What is the long-term trend for Integra LifeSciences's other commercial liabilities?: Over 5 years (2020 to 2025), Integra LifeSciences's other commercial liabilities has grown at a 6.7% compound annual growth rate (CAGR), from $94.19M to $130.49M.